Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies

Molecular Psychiatry

Volumn 22, Issue 4, 2017, Pages 497-511

  Xiao, X ^a   Chang, H ^a   Li, M ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; BIPOLAR DISORDER; ENHANCER REGION; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MENTAL DISEASE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREDICTION; PROMOTER REGION; QUANTITATIVE TRAIT LOCUS; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOME; GENOMICS; MENTAL HEALTH; METABOLISM; PROCEDURES; RISK FACTOR;

SPACER DNA; TRANSCRIPTOME;

DNA, INTERGENIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; MENTAL DISORDERS; MENTAL HEALTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANSCRIPTOME;

EID: 85007605391     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2016.241     Document Type: Review

References (171)

1. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291: 2581-2590.
2. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 2003; 123C: 48-58.
3. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187-1192.
4. Maier W, Lichtermann D, Minges J, Hallmayer J, Heun R, Benkert O et al. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch Gen Psychiatry 1993; 50: 871-883.
5. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371-1379.
6. Converge Consortium. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 2015; 523: 588-591.
7. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977-983.
8. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427.
9. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009; 459: 528-533.
10. Hyde CL, Nagle MW, Tian C, Chen X, Paciga SA, Wendland JR et al. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet 2016; 48: 1031-1036.
11. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012; 17: 142-153.
12. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014; 506: 179-184.
13. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014; 506: 185-190.
14. International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
15. Network Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 2015; 18: 199-209.
16. Schubert CR, Xi HS, Wendland JR, O'Donnell P. Translating human genetics into novel treatment targets for schizophrenia. Neuron 2014; 84: 537-541.
17. Okbay A, Baselmans BM, De Neve JE, Turley P, Nivard MG, Fontana MA et al. Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nat Genet 2016; 48: 624-633.
18. Hou L, Bergen SE, Akula N, Song J, Hultman CM, Landen M et al. Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder. Hum Mol Genet 2016; doi: 10.1093/hmg/ddw181.
19. Madras BK. History of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophrenia. J Hist Neurosci 2013; 22: 62-78.
20. Singh T, Kurki MI, Curtis D, Purcell SM, Crooks L, McRae J et al. Rare loss-offunction variants in SETD1A are associated with schizophrenia and developmental disorders. Nat Neurosci 2016; 19: 571-577.
21. Takata A, Ionita-Laza I, Gogos JA, Xu B, Karayiorgou M. De novo synonymous mutations in regulatory elements contribute to the genetic etiology of autism and schizophrenia. Neuron 2016; 89: 940-947.
22. Takata A, Xu B, Ionita-Laza I, Roos JL, Gogos JA, Karayiorgou M. Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene. Neuron 2014; 82: 773-780.
23. Straub RE, Weinberger DR. Schizophrenia genes-famine to feast. Biol Psychiatry 2006; 60: 81-83.
24. Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N et al. Schizophrenia risk from complex variation of complement component 4. Nature 2016; 530: 177-183.
25. Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry 2015; 77: 147-157.
26. Glausier JR, Lewis DA. Dendritic spine pathology in schizophrenia. Neuroscience 2013; 251: 90-107.
27. Schulze TG, Detera-Wadleigh SD, Akula N, Gupta A, Kassem L, Steele J et al. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 2009; 14: 487-491.
28. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056-1058.
29. Chen DT, Jiang X, Akula N, Shugart YY, Wendland JR, Steele CJ et al. Genomewide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry 2013; 18: 195-205.
30. Hughes T, Hansson L, Sonderby IE, Athanasiu L, Zuber V, Tesli M et al. A loss-offunction variant in a minor isoform of ANK3 protects against bipolar disorder and schizophrenia. Biol Psychiatry 2016; 80: 323-330.
31. Rueckert EH, Barker D, Ruderfer D, Bergen SE, O'Dushlaine C, Luce CJ et al. Cisacting regulation of brain-specific ANK3 gene expression by a genetic variant associated with bipolar disorder. Mol Psychiatry 2013; 18: 922-929.
32. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519-523.
33. Kleinman JE, Law AJ, Lipska BK, Hyde TM, Ellis JK, Harrison PJ et al. Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry 2011; 69: 140-145.
34. Gibbs JR, van der Brug MP, Hernandez DG, Traynor BJ, Nalls MA, Lai SL et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 2010; 6: e1000952.
35. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet 2013; 45: 580-585.
36. GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 2015; 348: 648-660.
37. Trabzuni D, Ryten M, Walker R, Smith C, Imran S, Ramasamy A et al. Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. J Neurochem 2011; 119: 275-282.
38. Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci 2014; 17: 1418-1428.
39. Fromer M, Roussos P, Sieberts SK, Johnson JS, Kavanagh DH, Perumal TM et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci 2016; 19: 1442-1453.
40. Heinzen EL, Ge D, Cronin KD, Maia JM, Shianna KV, Gabriel WN et al. Tissuespecific genetic control of splicing: implications for the study of complex traits. PLoS Biol 2008; 6: e1.
41. Liu C, Cheng L, Badner JA, Zhang D, Craig DW, Redman M et al. Whole-genome association mapping of gene expression in the human prefrontal cortex. Mol Psychiatry 2010; 15: 779-784.
42. Myers AJ, Gibbs JR, Webster JA, Rohrer K, Zhao A, Marlowe L et al. A survey of genetic human cortical gene expression. Nat Genet 2007; 39: 1494-1499.
43. Webster JA, Gibbs JR, Clarke J, Ray M, Zhang W, Holmans P et al. Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet 2009; 84: 445-458.
44. Zou F, Chai HS, Younkin CS, Allen M, Crook J, Pankratz VS et al. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet 2012; 8: e1002707.
45. McKenzie M, Henders AK, Caracella A, Wray NR, Powell JE. Overlap of expression quantitative trait loci (eQTL) in human brain and blood. BMC Med Genomics 2014; 7: 31.
46. Leek JT, Storey JD. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 2007; 3: 1724-1735.
47. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8: 118-127.
48. Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA et al. Integrated systems approach identifies genetic nodes and networks in lateonset Alzheimer's disease. Cell 2013; 153: 707-720.
49. Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, Yang F, Mattay V et al. A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med 2009; 15: 509-518.
50. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci USA 2006; 103: 6747-6752.
51. Li M, Jaffe AE, Straub RE, Tao R, Shin JH, Wang Y et al. A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophreniaassociated locus. Nat Med 2016; 22: 649-656.
52. Tao R, Cousijn H, Jaffe AE, Burnet PW, Edwards F, Eastwood SL et al. Expression of ZNF804A in human brain and alterations in schizophrenia, bipolar disorder, and major depressive disorder: a novel transcript fetally regulated by the psychosis risk variant rs1344706. JAMA Psychiatry 2014; 71: 1112-1120.
53. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008; 40: 1053-1055.
54. Riley B, Thiselton D, Maher BS, Bigdeli T, Wormley B, McMichael GO et al. Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Mol Psychiatry 2010; 15: 29-37.
55. Steinberg S, Mors O, Borglum AD, Gustafsson O, Werge T, Mortensen PB et al. Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry 2011; 16: 59-66.
56. Williams HJ, Norton N, Dwyer S, Moskvina V, Nikolov I, Carroll L et al. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry 2011; 16: 429-441.
57. Guella I, Sequeira A, Rollins B, Morgan L, Myers RM, Watson SJ et al. Evidence of allelic imbalance in the schizophrenia susceptibility gene ZNF804A in human dorsolateral prefrontal cortex. Schizophr Res 2014; 152: 111-116.
58. Guella I, Vawter MP. Allelic imbalance associated with the schizophrenia risk SNP rs1344706 indicates a cis-acting variant in ZNF804A. Schizophr Res 2014; 153: 243-245.
59. Hill MJ, Bray NJ. Evidence that schizophrenia risk variation in the ZNF804A gene exerts its effects during fetal brain development. Am J Psychiatry 2012; 169: 1301-1308.
60. Li YI, van de Geijn B, Raj A, Knowles DA, Petti AA, Golan D et al. RNA splicing is a primary link between genetic variation and disease. Science 2016; 352: 600-604.
61. BrainSeq: A Human Brain Genomics Consortium. BrainSeq: neurogenomics to drive novel target discovery for neuropsychiatric disorders. Neuron 2015; 88: 1078-1083.
62. Buonocore F, Hill MJ, Campbell CD, Oladimeji PB, Jeffries AR, Troakes C et al. Effects of cis-regulatory variation differ across regions of the adult human brain. Hum Mol Genet 2010; 19: 4490-4496.
63. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J et al. Genetics of gene expression and its effect on disease. Nature 2008; 452: 423-428.
64. Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, Heath S et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007; 448: 470-473.
65. Schliekelman P. Statistical power of expression quantitative trait loci for mapping of complex trait loci in natural populations. Genetics 2008; 178: 2201-2216.
66. Wang X, Gilbert H, Moreno C, Filangi O, Elsen JM, Le Roy P. Statistical properties of interval mapping methods on quantitative trait loci location: impact on QTL/ eQTL analyses. BMC Genet 2012; 13: 29.
67. Cheung VG, Spielman RS. Genetics of human gene expression: mapping DNA variants that influence gene expression. Nat Rev Genet 2009; 10: 595-604.
68. Westra HJ, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013; 45: 1238-1243.
69. Fehrmann RS, Jansen RC, Veldink JH, Westra HJ, Arends D, Bonder MJ et al. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet 2011; 7: e1002197.
70. Garnier S, Truong V, Brocheton J, Zeller T, Rovital M, Wild PS et al. Genome-wide haplotype analysis of cis expression quantitative trait loci in monocytes. PLoS Genet 2013; 9: e1003240.
71. Kumar V, Westra HJ, Karjalainen J, Zhernakova DV, Esko T, Hrdlickova B et al. Human disease-associated genetic variation impacts large intergenic noncoding RNA expression. PLoS Genet 2013; 9: e1003201.
72. Lappalainen T, Sammeth M, Friedlander MR, t Hoen PA, Monlong J, Rivas MA et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 2013; 501: 506-511.
73. Nica AC, Parts L, Glass D, Nisbet J, Barrett A, Sekowska M et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 2011; 7: e1002003.
74. Stranger BE, Montgomery SB, Dimas AS, Parts L, Stegle O, Ingle CE et al. Patterns of cis regulatory variation in diverse human populations. PLoS Genet 2012; 8: e1002639.
75. Akula N, Barb J, Jiang X, Wendland JR, Choi KH, Sen SK et al. RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol Psychiatry 2014; 19: 1179-1185.
76. Choi KH, Higgs BW, Wendland JR, Song J, McMahon FJ, Webster MJ. Gene expression and genetic variation data implicate PCLO in bipolar disorder. Biol Psychiatry 2011; 69: 353-359.
77. Matigian N, Windus L, Smith H, Filippich C, Pantelis C, McGrath J et al. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Mol Psychiatry 2007; 12: 815-825.
78. Seifuddin F, Pirooznia M, Judy JT, Goes FS, Potash JB, Zandi PP. Systematic review of genome-wide gene expression studies of bipolar disorder. BMC Psychiatry 2013; 13: 213.
79. Shao L, Vawter MP. Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry 2008; 64: 89-97.
80. Zhao Z, Xu J, Chen J, Kim S, Reimers M, Bacanu SA et al. Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder. Mol Psychiatry 2015; 20: 563-572.
81. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 2006; 11: 965-978.
82. Cruceanu C, Tan PP, Rogic S, Lopez JP, Torres-Platas SG, Gigek CO et al. Transcriptome sequencing of the anterior cingulate in bipolar disorder: dysregulation of G protein-coupled receptors. Am J Psychiatry 2015; 172: 1131-1140.
83. Gao L, Gao Y, Xu E, Xie J. Microarray analysis of the major depressive disorder mRNA profile data. Psychiatry Investig 2015; 12: 388-396.
84. Jansen R, Penninx BW, Madar V, Xia K, Milaneschi Y, Hottenga JJ et al. Gene expression in major depressive disorder. Mol Psychiatry 2016; 21: 339-347.
85. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Reddy R, Aschner M, Lewis DA et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 2011; 16: 751-762.
86. Barnes MR, Huxley-Jones J, Maycox PR, Lennon M, Thornber A, Kelly F et al. Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia. J Neurosci Res 2011; 89: 1218-1227.
87. Maycox PR, Kelly F, Taylor A, Bates S, Reid J, Logendra R et al. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 2009; 14: 1083-1094.
88. Mistry M, Gillis J, Pavlidis P. Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol Psychiatry 2013; 18: 215-225.
89. Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 2013; 18: 206-214.
90. Sainz J, Mata I, Barrera J, Perez-Iglesias R, Varela I, Arranz MJ et al. Inflammatory and immune response genes have significantly altered expression in schizophrenia. Mol Psychiatry 2013; 18: 1056-1057.
91. Leonard S, Logel J, Luthman D, Casanova M, Kirch D, Freedman R. Biological stability of mRNA isolated from human postmortem brain collections. Biol Psychiatry 1993; 33: 456-466.
92. Mehta D, Menke A, Binder EB. Gene expression studies in major depression. Curr Psychiatry Rep 2010; 12: 135-144.
93. Gamazon ER, Badner JA, Cheng L, Zhang C, Zhang D, Cox NJ et al. Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants. Mol Psychiatry 2013; 18: 340-346.
94. Richards AL, Jones L, Moskvina V, Kirov G, Gejman PV, Levinson DF et al. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Mol Psychiatry 2012; 17: 193-201.
95. Bacanu SA, Chen J, Sun J, Richardson K, Lai CQ, Zhao Z et al. Functional SNPs are enriched for schizophrenia association signals. Mol Psychiatry 2014; 19: 276-277.
96. Encode Project Consortium. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 2011; 9: e1001046.
97. Roadmap Epigenomics Consortium, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A et al. Integrative analysis of 111 reference human epigenomes. Nature 2015; 518: 317-330.
98. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012; 22: 1790-1797.
99. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012; 40: D930-D934.
100. Ritchie GR, Dunham I, Zeggini E, Flicek P. Functional annotation of noncoding sequence variants. Nat Methods 2014; 11: 294-296.
101. Coetzee SG, Rhie SK, Berman BP, Coetzee GA, Noushmehr H. FunciSNP: an R/ bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Res 2012; 40: e139.
102. Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 2013; 41: D64-D69.
103. Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D et al. The UCSC Table Browser data retrieval tool. Nucleic Acids Res 2004; 32: D493-D496.
104. Griffiths A, Wessler S, Lewontin R, Carroll S. Introduction to Genetic Analysis (W. H. Freeman and Company; 9th edition (February 16, 2007)).
105. Tycko B. Mapping allele-specific DNA methylation: a new tool for maximizing information from GWAS. Am J Hum Genet 2010; 86: 109-112.
106. Meaburn EL, Schalkwyk LC, Mill J. Allele-specific methylation in the human genome: implications for genetic studies of complex disease. Epigenetics 2010; 5: 578-582.
107. Hannon E, Spiers H, Viana J, Pidsley R, Burrage J, Murphy TM et al. Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat Neurosci 2016; 19: 48-54.
108. Jaffe AE, Gao Y, Deep-Soboslay A, Tao R, Hyde TM, Weinberger DR et al. Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex. Nat Neurosci 2016; 19: 40-47.
109. Gagliano SA, Ptak C, Mak DY, Shamsi M, Oh G, Knight J et al. Allele-skewed DNA modification in the brain: relevance to a schizophrenia GWAS. Am J Hum Genet 2016; 98: 956-962.
110. Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson ND et al. Global epigenomic reconfiguration during mammalian brain development. Science 2013; 341: 1237905.
111. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z et al. Highresolution mapping and characterization of open chromatin across the genome. Cell 2008; 132: 311-322.
112. Yatabe Y, Tavare S, Shibata D. Investigating stem cells in human colon by using methylation patterns. Proc Natl Acad Sci USA 2001; 98: 10839-10844.
113. Psych Encode Consortium, Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ et al. The PsychENCODE project. Nat Neurosci 2015; 18: 1707-1712.
114. Sexton T, Bantignies F, Cavalli G. Genomic interactions: chromatin loops and gene meeting points in transcriptional regulation. Semin Cell Dev Biol 2009; 20: 849-855.
115. Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. Science 2002; 295: 1306-1311.
116. French JD, Ghoussaini M, Edwards SL, Meyer KB, Michailidou K, Ahmed S et al. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet 2013; 92: 489-503.
117. Praetorius C, Grill C, Stacey SN, Metcalf AM, Gorkin DU, Robinson KC et al. A polymorphism in IRF4 affects human pigmentation through a tyrosinasedependent MITF/TFAP2A pathway. Cell 2013; 155: 1022-1033.
118. Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, Haugen C et al. FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 2015; 373: 895-907.
119. Duan J, Shi J, Fiorentino A, Leites C, Chen X, Moy W et al. A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder. Am J Hum Genet 2014; 95: 744-753.
120. Roussos P, Mitchell AC, Voloudakis G, Fullard JF, Pothula VM, Tsang J et al. A role for noncoding variation in schizophrenia. Cell Rep 2014; 9: 1417-1429.
121. Gershon ES, Grennan K, Busnello J, Badner JA, Ovsiew F, Memon S et al. A rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain. Mol Psychiatry 2014; 19: 890-894.
122. Bigos KL, Mattay VS, Callicott JH, Straub RE, Vakkalanka R, Kolachana B et al. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiatry 2010; 67: 939-945.
123. Yoshimizu T, Pan JQ, Mungenast AE, Madison JM, Su S, Ketterman J et al. Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons. Mol Psychiatry 2015; 20: 162-169.
124. Eckart N, Song Q, Yang R, Wang R, Zhu H, McCallion AS et al. Functional characterization of schizophrenia-associated variation in CACNA1C. PLoS One 2016; 11: e0157086.
125. Dostie J, Richmond TA, Arnaout RA, Selzer RR, Lee WL, Honan TA et al. Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements. Genome Res 2006; 16: 1299-1309.
126. Belton JM, McCord RP, Gibcus JH, Naumova N, Zhan Y, Dekker J. Hi-C: a comprehensive technique to capture the conformation of genomes. Methods 2012; 58: 268-276.
127. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009; 462: 58-64.
128. Li G, Ruan X, Auerbach RK, Sandhu KS, Zheng M, Wang P et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 2012; 148: 84-98.
129. Chepelev I, Wei G, Wangsa D, Tang Q, Zhao K. Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization. Cell Res 2012; 22: 490-503.
130. Handoko L, Xu H, Li G, Ngan CY, Chew E, Schnapp M et al. CTCF-mediated functional chromatin interactome in pluripotent cells. Nat Genet 2011; 43: 630-638.
131. Patel B, Kang Y, Cui K, Litt M, Riberio MS, Deng C et al. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia. Leukemia 2014; 28: 349-361.
132. Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 2011; 470: 264-268.
133. Rhie SK, Coetzee SG, Noushmehr H, Yan C, Kim JM, Haiman CA et al. Comprehensive functional annotation of seventy-one breast cancer risk Loci. PLoS One 2013; 8: e63925.
134. Huang HS, Matevossian A, Jiang Y, Akbarian S. Chromatin immunoprecipitation in postmortem brain. J Neurosci Methods 2006; 156: 284-292.
135. Li M, Luo XJ, Xiao X, Shi L, Liu XY, Yin LD et al. Allelic differences between Han Chinese and Europeans for functional variants in ZNF804A and their association with schizophrenia. Am J Psychiatry 2011; 168: 1318-1325.
136. Hill MJ, Bray NJ. Allelic differences in nuclear protein binding at a genome-wide significant risk variant for schizophrenia in ZNF804A. Mol Psychiatry 2011; 16: 787-789.
137. Kandaswamy R, McQuillin A, Sharp SI, Fiorentino A, Anjorin A, Blizard RA et al. Genetic association, mutation screening, and functional analysis of a Kozak sequence variant in the metabotropic glutamate receptor 3 gene in bipolar disorder. JAMA Psychiatry 2013; 70: 591-598.
138. Butter F, Davison L, Viturawong T, Scheibe M, Vermeulen M, Todd JA et al. Proteome-wide analysis of disease-associated SNPs that show allele-specific transcription factor binding. PLoS Genet 2012; 8: e1002982.
139. Desviat LR, Perez B, Ugarte M. Minigenes to confirm exon skipping mutations. Methods Mol Biol 2012; 867: 37-47.
140. Cooper TA. Use of minigene systems to dissect alternative splicing elements. Methods 2005; 37: 331-340.
141. Cohen OS, Weickert TW, Hess JL, Paish LM, McCoy SY, Rothmond DA et al. A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples. Mol Psychiatry 2015; 21: 975-982.
142. Seo S, Takayama K, Uno K, Ohi K, Hashimoto R, Nishizawa D et al. Functional analysis of deep intronic SNP rs13438494 in intron 24 of PCLO gene. PLoS One 2013; 8: e76960.
143. Carr GV, Chen J, Yang F, Ren M, Yuan P, Tian Q et al. KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia. Mol Psychiatry 2016; 21: 1517-1526.
144. Liu Z, Li X, Zhang JT, Cai YJ, Cheng TL, Cheng C et al. Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2. Nature 2016; 530: 98-102.
145. Byrne SM, Mali P, Church GM. Genome editing in human stem cells. Methods Enzymol 2014; 546: 119-138.
146. Pak C, Danko T, Zhang Y, Aoto J, Anderson G, Maxeiner S et al. Human neuropsychiatric disease modeling using conditional deletion reveals synaptic transmission defects caused by heterozygous mutations in NRXN1. Cell Stem Cell 2015; 17: 316-328.
147. Srikanth P, Han K, Callahan DG, Makovkina E, Muratore CR, Lalli MA et al. Genomic DiSC1 disruption in hiPSCs alters Wnt signaling and neural cell fate. Cell Rep 2015; 12: 1414-1429.
148. Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ. Catechol-Omethyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 2004; 24: 5331-5335.
149. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004; 75: 807-821.
150. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-6922.
151. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995; 34: 4202-4210.
152. Palmatier MA, Kang AM, Kidd KK. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 1999; 46: 557-567.
153. Barkus C, Korn C, Stumpenhorst K, Laatikainen L, Ballard D, Lee S et al. Genotypedependent effects of COMT inhibition on cognitive function in a highly-specific, novel mouse model of altered COMT activity. Neuropsychopharmacology 2016; 41: 3060-3069.
154. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V et al. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 2000; 28: 316-319.
155. Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ et al. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res 2014; 42: D142-D147.
156. Marinescu VD, Kohane IS, Riva A. The MAPPER database: a multi-genome catalog of putative transcription factor binding sites. Nucleic Acids Res 2005; 33: D91-D97.
157. Li MJ, Wang LY, Xia Z, Sham PC, Wang J. GWAS3D: Detecting human regulatory variants by integrative analysis of genome-wide associations, chromosome interactions and histone modifications. Nucleic Acids Res 2013; 41: W150-W158.
158. Zhou J, Troyanskaya OG. Predicting effects of noncoding variants with deep learning-based sequence model. Nat Methods 2015; 12: 931-934.
159. Liu T, Ortiz JA, Taing L, Meyer CA, Lee B, Zhang Y et al. Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol 2011; 12: R83.
160. Grunau C, Renault E, Rosenthal A, Roizes G. MethDB-a public database for DNA methylation data. Nucleic Acids Res 2001; 29: 270-274.
161. Amoreira C, Hindermann W, Grunau C. An improved version of the DNA Methylation database (MethDB). Nucleic Acids Res 2003; 31: 75-77.
162. Bock C, Walter J, Paulsen M, Lengauer T. CpG island mapping by epigenome prediction. PLoS Comput Biol 2007; 3: e110.
163. Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M et al. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet 2012; 90: 260-272.
164. Ernst J, Kellis M. ChromHMM: automating chromatin-state discovery and characterization. Nat Methods 2012; 9: 215-216.
165. Manke T, Heinig M, Vingron M. Quantifying the effect of sequence variation on regulatory interactions. Hum Mutat 2010; 31: 477-483.
166. Wei Y, Zhang S, Shang S, Zhang B, Li S, Wang X et al. SEA: a super-enhancer archive. Nucleic Acids Res 2016; 44: D172-D179.
167. Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009; 326: 289-293.
168. Xie X, Ma W, Songyang Z, Luo Z, Huang J, Dai Z et al. CCSI: a database providing chromatin-chromatin spatial interaction information. Database (Oxford) 2016; 2016: bav124.
169. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol 2004; 2: e363.
170. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
171. Barenboim M, Zoltick BJ, Guo Y, Weinberger DR. MicroSNiPer: a web tool for prediction of SNP effects on putative microRNA targets. Hum Mutat 2010; 31: 1223-1232.